<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">52612</article-id><article-id pub-id-type="doi">10.7554/eLife.52612</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Opposite changes in APP processing and human aβ levels in rats carrying either a protective or a pathogenic APP mutation</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-162415"><name><surname>Tambini</surname><given-names>Marc D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-162567"><name><surname>Norris</surname><given-names>Kelly A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-160379"><name><surname>D'Adamio</surname><given-names>Luciano</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2204-9441</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Pharmacology, Physiology and Neuroscience</institution>, <institution>Rutgers, The State University of New Jersey</institution>, <addr-line><named-content content-type="city">Newark</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-64900"><name><surname>West</surname><given-names>Andrew B</given-names></name><role>Reviewing editor</role><aff><institution>Duke University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>luciano.dadamio@rutgers.edu</email> (LD);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>05</day><month>02</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e52612</elocation-id><history><date date-type="received"><day>09</day><month>10</month><year>2019</year></date><date date-type="accepted"><day>03</day><month>02</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Tambini et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Tambini et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-52612-v1.pdf"/><abstract><p>Cleavage of APP by BACE1/b-secretase initiates the amyloidogenic cascade leading to Amyloid-b (Ab) production. a-Secretase initiates the non-amyloidogenic pathway preventing Ab production. Several <italic>APP</italic> mutations cause familial Alzheimer's disease (AD), while the Icelandic <italic>APP</italic> mutation near the BACE1-cleavage site protects from sporadic dementia, emphasizing APP's role in dementia pathogenesis. To study APP protective/pathogenic mechanisms, we generated knock-in rats carrying either the protective (<italic>App<sup>p</sup></italic>) or the pathogenic Swedish mutation (<italic>App<sup>s</sup></italic>), also located near the BACE1-cleavage site. a-Cleavage is favored over b-processing in <italic>App<sup>p</sup></italic> rats. Consequently, non-amyloidogenic and amyloidogenic APP metabolites are increased and decreased, respectively. The reverse APP processing shift occurs in <italic>App<sup>s</sup></italic> rats. These opposite effects on APP b/a-processing suggest that protection from and pathogenesis of dementia depend upon combinatorial and opposite alterations in APP metabolism rather than simply on Ab levels. The Icelandic mutation also protects from aging-dependent cognitive decline, suggesting that similar mechanisms underlie physiological cognitive aging.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Rat</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000049</institution-id><institution>National Institute on Aging</institution></institution-wrap></funding-source><award-id>R01AG063407</award-id><principal-award-recipient><name><surname>D'Adamio</surname><given-names>Luciano</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000049</institution-id><institution>National Institute on Aging</institution></institution-wrap></funding-source><award-id>RF1AG064821</award-id><principal-award-recipient><name><surname>D'Adamio</surname><given-names>Luciano</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Rats were handled according to the Ethical Guidelines for Treatment of Laboratory Animals of the NIH. The procedures were described and approved by the Institutional Animal Care and Use Committee (IACUC) at Rutgers University.(protocol number 201702513).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated and analyzed are included. Source files have been provided for all Figures</p></sec><supplementary-material><ext-link xlink:href="elife-52612-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>